MONTELEONE, FABRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.556
EU - Europa 264
AS - Asia 146
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 2
Totale 3.972
Nazione #
US - Stati Uniti d'America 3.555
KR - Corea 76
IT - Italia 63
IE - Irlanda 60
CN - Cina 49
DE - Germania 44
UA - Ucraina 35
GB - Regno Unito 13
SG - Singapore 13
FR - Francia 11
PL - Polonia 11
RU - Federazione Russa 11
SE - Svezia 8
FI - Finlandia 4
AU - Australia 2
BR - Brasile 2
EU - Europa 2
GR - Grecia 2
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
JP - Giappone 1
LK - Sri Lanka 1
MY - Malesia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 3.972
Città #
Wilmington 1.113
Houston 984
Woodbridge 648
Fairfield 130
Chandler 129
Ann Arbor 66
New York 64
Ashburn 58
Dublin 49
Seattle 49
Cambridge 47
Dearborn 40
Medford 28
Jacksonville 22
Rome 16
Lawrence 14
Roebling 14
Beijing 13
Kraków 11
Moscow 8
Norwalk 8
Singapore 8
Zhengzhou 7
San Diego 6
Philadelphia 5
San Jose 5
Palo Alto 4
Redwood City 4
Seoul 4
Shanghai 4
Detroit 3
Hefei 3
Kunming 3
Nanjing 3
Turin 3
Verona 3
Arosio 2
Camino al Tagliamento 2
Chongqing 2
Del Norte 2
Frankfurt am Main 2
Guangzhou 2
Lissone 2
Menlo Park 2
Milan 2
Nanchang 2
Parma 2
Pavia 2
Piove di Sacco 2
São Paulo 2
Ardea 1
Bangkok 1
Brno 1
Buffalo 1
Caserta 1
Central 1
Chengdu 1
Chiswick 1
Colombo 1
Fuzhou 1
Haikou 1
Hangzhou 1
Huzhou 1
Jinan 1
Jinhua 1
Kilburn 1
Kuala Lumpur 1
Lappeenranta 1
Lodi 1
London 1
Mcallen 1
Mountain View 1
Novokuznetsk 1
Nürnberg 1
Paris 1
Pescara 1
Pomezia 1
Pullach im Isartal 1
Pune 1
Redmond 1
Sabz 1
Saint Paul 1
Saint Petersburg 1
Stanmore 1
Strasbourg 1
Sydney 1
Toronto 1
Wakefield 1
Xian 1
Totale 3.643
Nome #
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis 417
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 381
Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain 361
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids 347
Reversible hyporegenerative anemia during natalizumab treatment 340
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 294
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 291
Safety, tolerability and effectiveness of dimethyl fumarate in multiple sclerosis: an independent, multicenter, real-world study 280
TRPV1 channels regulate cortical excitability in humans 259
Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis 258
Enhancing brain plasticity to contrast clinical progression in MS: a pilot study assessing the safety and efficacy of D-Aspartate 243
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 158
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 152
The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray) 142
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 34
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 29
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 19
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray) 19
CSF tau levels influence cortical plasticity in Alzheimer's disease patients 8
null 3
Totale 4.035
Categoria #
all - tutte 8.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.247 90 90 82 109 91 134 131 108 130 104 83 95
2020/2021800 88 101 88 103 80 96 86 95 15 22 14 12
2021/2022139 10 12 0 4 3 17 11 8 5 19 17 33
2022/2023345 25 24 50 67 22 58 28 17 32 2 12 8
2023/2024109 21 4 5 10 8 33 2 8 2 0 0 16
2024/20259 9 0 0 0 0 0 0 0 0 0 0 0
Totale 4.035